Birch Hill Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481K Sell
19,955
-1,500
-7% -$39.2K 0.02% 154
2026
Q1
$602K Sell
21,455
-475
-2% -$12.6K 0.03% 139
2025
Q4
$546K Buy
21,930
+1,475
+7% +$37.2K 0.02% 143
2025
Q3
$521K Hold
20,455
0.02% 141
2025
Q2
$496K Sell
20,455
-350
-2% -$8.16K 0.02% 141
2025
Q1
$527K Sell
20,805
-2,150
-9% -$56.3K 0.03% 137
2024
Q4
$609K Sell
22,955
-3,587
-14% -$97.3K 0.03% 132
2024
Q3
$768K Sell
26,542
-1,500
-5% -$43.8K 0.04% 115
2024
Q2
$785K Buy
28,042
+2,500
+10% +$68.8K 0.04% 113
2024
Q1
$709K Sell
25,542
-1,879
-7% -$52.1K 0.03% 111
2023
Q4
$789K Sell
27,421
-2,497
-8% -$75.5K 0.04% 106
2023
Q3
$992K Sell
29,918
-346
-1% -$12.2K 0.06% 97
2023
Q2
$1.11M Buy
30,264
+897
+3% +$34.9K 0.06% 92
2023
Q1
$1.2M Sell
29,367
-260
-0.9% -$11.2K 0.07% 89
2022
Q4
$1.52M Hold
29,627
0.1% 83
2022
Q3
$1.3M Sell
29,627
-219
-0.7% -$10.6K 0.09% 87
2022
Q2
$1.56M Buy
29,846
+160
+0.5% +$8.15K 0.1% 82
2022
Q1
$1.54M Sell
29,686
-650
-2% -$33.7K 0.08% 89
2021
Q4
$1.79M Sell
30,336
-1,120
-4% -$55.5K 0.09% 84
2021
Q3
$1.35M Buy
31,456
+1,615
+5% +$71.5K 0.07% 87
2021
Q2
$1.17M Sell
29,841
-400
-1% -$15.6K 0.06% 91
2021
Q1
$1.1M Sell
30,241
-12,500
-29% -$444K 0.06% 91
2020
Q4
$1.57M Sell
42,741
-4,126
-9% -$151K 0.09% 81
2020
Q3
$1.63M Buy
46,867
+790
+2% +$27.7K 0.11% 75
2020
Q2
$1.43M Buy
46,077
+527
+1% +$17.9K 0.1% 75
2020
Q1
$1.41M Sell
45,550
-8,536
-16% -$291K 0.12% 72
2019
Q4
$2.01M Buy
54,086
+1,370
+3% +$48.8K 0.13% 70
2019
Q3
$1.8M Buy
52,716
+539
+1% +$19.6K 0.13% 71
2019
Q2
$2.15M Sell
52,177
-2,240
-4% -$88.9K 0.16% 68
2019
Q1
$2.19M Sell
54,417
-3,531
-6% -$141K 0.17% 71
2018
Q4
$2.4M Hold
57,948
0.21% 65
2018
Q3
$2.42M Buy
57,948
+6,524
+13% +$251K 0.18% 69
2018
Q2
$1.77M Buy
51,424
+9,671
+23% +$330K 0.14% 73
2018
Q1
$1.41M Buy
41,753
+15,910
+62% +$547K 0.12% 72
2017
Q4
$888K Sell
25,843
-148
-0.6% -$5.05K 0.07% 82
2017
Q3
$880K Hold
25,991
0.08% 80
2017
Q2
$828K Sell
25,991
-421
-2% -$13.3K 0.07% 81
2017
Q1
$857K Buy
26,412
+147
+0.6% +$4.63K 0.07% 81
2016
Q4
$809K Sell
26,265
-2,108
-7% -$64.4K 0.07% 80
2016
Q3
$912K Hold
28,373
0.08% 79
2016
Q2
$948K Sell
28,373
-210
-0.7% -$6.7K 0.09% 78
2016
Q1
$804K Sell
28,583
-1,687
-6% -$48.2K 0.08% 81
2015
Q4
$927K Sell
30,270
-938
-3% -$29.5K 0.1% 80
2015
Q3
$930K Sell
31,208
-5,745
-16% -$184K 0.1% 79
2015
Q2
$1.18M Sell
36,953
-211
-0.6% -$6.88K 0.12% 76
2015
Q1
$1.23M Sell
37,164
-4,680
-11% -$149K 0.13% 76
2014
Q4
$1.24M Sell
41,844
-527
-1% -$15.1K 0.13% 76
2014
Q3
$1.19M Hold
42,371
0.12% 75
2014
Q2
$1.19M Hold
42,371
0.12% 73
2014
Q1
$1.29M Buy
42,371
+3,522
+9% +$105K 0.14% 72
2013
Q4
$1.13M Buy
38,849
+632
+2% +$18.4K 0.12% 77
2013
Q3
$1.04M Sell
38,217
-105
-0.3% -$2.86K 0.12% 78
2013
Q2
$1.02M Buy
+38,322
New +$1.06M 0.13% 78

Other funds holding PFE

Birch Hill Investment Advisors's PFE Position: Q2 2026 in Review

Birch Hill Investment Advisors reduced its Pfizer (PFE) stake by 7% in Q2 2026, selling an estimated $39.2K and leaving 19,955 shares worth $481K. The position accounts for 0.02% of the portfolio, ranked #154.

Birch Hill Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.42M in Q3 2018. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Birch Hill Investment Advisors held 19,955 shares of Pfizer worth $481K as of Q2 2026.
  • Birch Hill Investment Advisors sold 1,500 Pfizer shares in Q2 2026, an estimated $39.2K.
  • Pfizer made up 0.02% of Birch Hill Investment Advisors's portfolio in Q2 2026, its #154 holding.
  • Birch Hill Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Birch Hill Investment Advisors's Pfizer position peaked at $2.42M in Q3 2018.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Birch Hill Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.